-
A total of 1,857 patients (male 768, 41.4%) were enrolled in this study. Mean age of the patients was 61.5 ± 8.7 years and mean DM duration was 7.6 ± 5.9 years. Mean SBP, DBP, and IOP were 147.39 ± 23.32 mmHg, 77.35 ± 11.36 mmHg, and 15.6 ± 3.4 mmHg, respectively. Male patients had lower SBP (146.14 ± 21.70 vs. 148.27 ± 24.37 mmHg, P = 0.048) and higher DBP (79.28 ± 11.63 vs. 75.99 ± 10.96 mmHg, P < 0.001) relative to their female counterparts. There was no significant difference in IOP between males and females (15.5 ± 3.4 vs. 15.8 ± 3.5 mmHg, P = 0.06). A total of 61.9% of patients had mean SBP ≥ 140 mmHg or DBP ≥ 90 mmHg, while 6.4% patients had an IOP ≥ 21 mmHg. Table 1 shows the characteristics of patients with or without DR by sex.
Item Overall Men Women No DR
(n = 1,151)DR
(n = 706)P No DR
(n = 491)DR
(n = 277)P No DR
(n = 660)DR
(n = 429)P Age 61.7 ± 8.7 61.1 ± 8.6 0.16 61.2 ± 9.4 59.6 ± 8.4 0.01 62.0 ± 8.2 62.1 ± 8.5 0.91 Male, n (%) 491 (42.7) 277 (39.2) 0.15 − − − − Duration of diabetes (years) 5.7 ± 4.8 10.6 ± 6.2 < 0.001 5.2 ± 4.6 10.5 ± 6.2 < 0.001 6.1 ± 4.9 10.6 ± 6.2 < 0.001 FPG (mmol/L) 8.7 ± 2.9 10.4 ± 3.9 < 0.001 8.9 ± 2.9 10.7 ± 4.0 < 0.001 8.6 ± 2.9 10.3 ± 3.9 < 0.001 HbA1c (%) 7.4 ± 1.9 8.3 ± 2.1 < 0.001 7.4 ± 1.9 8.5 ± 2.2 < 0.001 7.4 ± 1.8 8.2 ± 2.1 < 0.001 BMI (kg/m2) 26.49 ± 3.43 26.23 ± 3.42 0.11 26.44 ± 3.14 25.99 ± 2.96 0.051 26.52 ± 3.63 26.38 ± 3.68 0.054 SBP (mmHg) 144.47 ± 22.80 152.15 ± 23.39 < 0.001 143.71 ± 21.27 150.45 ± 21.82 < 0.001 145.04 ± 23.88 153.25 ± 24.30 < 0.001 DBP (mmHg) 77.08 ± 10.92 77.80 ± 12.03 0.19 78.95 ± 11.06 79.87 ± 12.58 0.31 75.69 ± 10.62 76.46 ± 11.48 0.25 High BP, n (%) 654 (56.8) 496 (70.2) < 0.001 289 (58.9) 191 (69.0) 0.006 365 (55.3) 305 (71.1) < 0.001 MAP 99.54 ± 12.96 102.58 ± 13.84 < 0.001 100.53 ± 12.64 103.40 ± 13.78 0.004 98.80 ± 13.15 102.06 ± 13.87 < 0.001 IOP 15.63 ± 3.59 15.66 ± 3.16 0.86 15.49 ± 3.53 15.42 ± 3.06 0.79 15.74 ± 3.64 15.81 ± 3.22 0.73 High IOP, n (%) 84 (7.3) 34 (4.8) 0.03 37 (7.5) 10 (3.6) 0.03 47 (7.1) 24 (5.6) 0.32 MOPP 50.73 ± 8.43 52.73 ± 9.15 < 0.001 51.54 ± 8.38 53.51 ± 9.25 0.003 50.13 ± 8.43 52.23 ± 9.07 < 0.001 Note. FPG: fasting plasma glucose; HbA1c: glycosylated hemoglobin A1c; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; IOP: intraocular pressure; MOPP: mean ocular perfusion pressure; DR: diabetic retinopathy. High BP is defined as SBP ≥ 140 mmHg or DBP ≥ 90 mmHg; high IOP is defined as IOP ≥ 21 mmHg. Table 1. Characteristics of patients with or without diabetic retinopathy by sex
Table 2 shows the mean MOPP value for male, female, and combined male and female patients. Mean MOPP for all patients was 51.49 ± 8.77 mmHg. Male patients had a higher MOPP than female patients (52.25 ± 8.75 vs. 50.96 ± 8.74 mmHg, P = 0.002). Both male and female patients (and combined male and female patients) with any type of DR or NPDR had significantly higher MOPP values than patients without DR. Male patients (and combined male and female patients) with ME also had significantly higher MOPP values than did patients without ME.
Item Overall Male Female n Mean ± SD P n Mean ± SD P n Mean ± SD P Overall 1,857 51.49 ± 8.77 − 768 52.25 ± 8.75 − 1,089 50.96 ± 8.74 − Retinopathy No DR 1,151 50.73 ± 8.43 Ref 491 51.54 ± 8.38 Ref 660 50.13 ± 8.43 Ref Any DR 706 52.73 ± 9.15 < 0.001 277 53.51 ± 9.25 0.003 429 52.23 ± 9.07 < 0.001 NPDR 639 52.74 ± 9.23 Sig 251 53.32 ± 9.30 Sig 388 52.37 ± 9.18 Sig PDR 67 52.62 ± 8.40 NS 26 55.33 ± 8.71 NS 41 50.89 ± 7.82 NS Non-STDR 516 52.72 ± 9.44 Sig 205 53.19 ± 9.68 NS 311 52.40 ± 9.28 Sig STDR 190 52.76 ± 8.34 Sig 72 54.41 ± 7.88 Sig 118 51.76 ± 8.48 NS Maculopathy No ME 1,548 51.17 ± 8.64 Ref 656 51.86 ± 8.72 Ref 892 50.67 ± 8.56 Ref ME 250 53.01 ± 9.26 0.002 89 54.78 ± 8.75 0.003 161 52.03 ± 9.41 0.070 Non-CSME 120 53.58 ± 10.08 Sig 42 55.80 ± 9.35 Sig 78 52.39 ± 10.31 NS CSME 130 52.47 ± 8.43 NS 47 53.87 ± 8.17 NS 83 51.69 ± 8.52 NS Note. MOPP: mean ocular perfusion pressure; DR: diabetic retinopathy; NPDR: non-proliferative DR; PDR: proliferative DR; STDR: sight-threatening DR; ME: macular edema; CSME: clinically significant ME; SD: standard deviation; Ref: reference group; Sig: significant; NS: not significant. Table 2. MOPP values by sex in the study population
Table 3 shows the multivariate linear regression results for the factors associated with MOPP. Table 4 shows the association between DR prevalence and the risk factors. In a stepwise multivariate regression model, we found that sex, FPG, BMI, serum creatinine, LDL, HDL, and urine protein levels were significantly associated with MOPP. Furthermore, WHR and blood urea nitrogen were almost significantly associated with MOPP (Table 3). We also found that MOPP, age, refractive error, income level, DM duration, FPG, HbA1c, TG, and urine protein levels were significantly associated with DR after adjusting for MOPP and similar risk factors in a multivariate logistical model. Furthermore, TC was almost significantly associated with DR (Table 4).
Factors β coefficient 95% CI Standardized β coefficient P value VIF Sex (male, female) −0.90 −1.78, −0.03 −0.05 0.04 1.23 Fasting plasma glucose (mmol/L) 0.13 0.02, 0.25 0.05 0.03 1.04 Body mass index (kg/m2) 0.40 0.28, 0.51 0.15 < 0.001 1.05 Waist/hip ratio 5.91 −0.20, 12.02 0.04 0.06 1.04 Serum creatinine (μmmol/L) 0.03 0.01, 0.06 0.08 0.002 1.21 Blood urea nitrogen (mmol/L) −0.12 −0.24, 0.01 −0.04 0.06 1.06 Low-density lipoprotein (mmol/L) 0.58 0.15, 1.00 0.06 0.01 1.07 High-density lipoprotein (mmol/L) −1.26 −2.34, −0.17 −0.05 0.02 1.09 Urine protein level (5 levels) 0.71 0.43, 0.99 0.11 < 0.001 1.03 Note. CI: confidence interval; MOPP: mean ocular perfusion pressure; VIF: variance inflation factor. Table 3. Factors associated with MOPP in the study population
Risk factors OR (95% CI) P value MOPP (mmHg) 1.03 (1.02, 1.04) < 0.001 Age (years) 0.98 (0.97, 0.99) 0.002 Refractive error (diopter) 1.07 (1.02, 1.11) 0.002 Income level (3 levels) 0.76 (0.62, 0.92) 0.006 Duration of DM (years) 1.17 (1.15, 1.20) < 0.001 Fasting plasma glucose (mmol/L) 1.07 (1.02, 1.11) 0.003 HbA1c (%) 1.12 (1.05, 1.20) 0.001 Total cholesterol (mmol/L) 1.09 (1.00, 1.20) 0.056 Total triglycerides (mmol/L) 0.90 (0.84, 0.97) 0.005 Urine protein level (5 levels) 1.17 (1.08, 1.26) < 0.001 Note. OR: odds ratio; CI: confidence interval; MOPP: mean ocular perfusion pressure; DM: diabetes mellitus; HbA1c: glycosylated hemoglobin A1c. Table 4. PLEASE SEE the table of the supplement word file in reply email, since it was changed much
In further logistic analyses, after adjusting for factors remaining in the previous multivariate regression model, we found that increased MOPP (per 1 mmHg) was significantly associated with the presence of any type of DR [odds (OR) = 1.03, 95% confidence interval (CI): 1.02–1.04, P < 0.001], NPDR (OR = 1.03, 95% CI: 1.02–1.04, P < 0.001), and non-STDR (OR = 1.03, 95% CI: 1.01–1.04, P < 0.001). Moreover, increased MOPP (per 1 mmHg) was found to be associated with increased ME likelihood (OR = 1.02, 95% CI: 1.01–1.04, P = 0.008). However, no significant association was found between MOPP and PDR, non-STDR and STDR, or non-CSME and CSME (Table 5) relative to NPDR.
Item OR (95% CI) P value No DR vs. Any DR 1.03 (1.02, 1.04) < 0.001 No DR vs. NPDR 1.03 (1.02, 1.04) < 0.001 NPDR vs. PDR 0.99 (0.96, 1.03) 0.660 No DR vs. non-STDR 1.03 (1.01, 1.04) < 0.001 non-STDR vs. STDR 1.00 (0.98, 1.02) 0.750 No ME vs. ME 1.02 (1.01, 1.04) 0.008 Non-CSME vs. CSME 0.99 (0.96, 1.02) 0.350 Note. MOPP: mean ocular perfusion pressure; DR: diabetic retinopathy; ME: macular edema; NPDR: non-proliferative DR; PDR: proliferative DR; CSME: clinically significant ME; OR: odds ratio; CI: confidence interval; STDR: sight-threatening DR. The multivariate logistic regression models adjusted for MOPP, age, refractive error, income level, duration of diabetes mellitus, fasting blood glucose, HbA1c, total cholesterol, total triglycerides, and urine protein level. Table 5. Multivariate logistic regression analysis of MOPP (per 1 mmHg) for the prevalence/severity of DR and ME
Association between Mean Ocular Perfusion Pressure and Diabetic Retinopathy in a Northeastern Chinese Population
doi: 10.3967/bes2020.091
- Received Date: 2019-10-28
- Accepted Date: 2020-01-16
-
Key words:
- Diabetic retinopathy /
- Ocular perfusion pressure /
- Systolic blood pressure /
- Diastolic blood pressure
Abstract:
Citation: | ZHAI Gang, LIN Zhong, WANG Feng Hua, WANG Yu, LI Dong, WEN Liang, DING Xiao Xia, JIANG Jing, FENG Ke Mi, LIANG Yuan Bo, XIE Cong. Association between Mean Ocular Perfusion Pressure and Diabetic Retinopathy in a Northeastern Chinese Population[J]. Biomedical and Environmental Sciences, 2020, 33(9): 701-707. doi: 10.3967/bes2020.091 |